Quick Answer
Protagenic Therapeutics, Inc.new reported Shares Outstanding of 7.24 million shares for fiscal year 2024.
Protagenic Therapeutics, Inc.new Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 7.24M | +63.3% |
| 2023 | 4.44M | +2.6% |
| 2022 | 4.32M | +0.4% |
| 2021 | 4.30M | -58.5% |
| 2020 | 10.36M | +1.0% |
| 2019 | 10.26M | +0.0% |
| 2018 | 10.26M | +0.0% |
| 2017 | 10.26M | +0.0% |
| 2016 | 10.26M | +55.1% |
| 2015 | 6.61M | -98.3% |
| 2015 | 400.00M | +0.0% |
| 2014 | 400.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 1.93M | +274.1% | +0.0% |
| September 30, 2025 | 1.93M | -59.7% | -66.6% |
| March 31, 2025 | 5.80M | +30.8% | +1021.3% |
| December 31, 2024 | 517,257 | -88.3% | -89.2% |
| September 30, 2024 | 4.80M | +10.9% | +7.6% |
| June 30, 2024 | 4.47M | +3.1% | +0.7% |
| March 31, 2024 | 4.44M | +2.4% | +0.0% |
| December 31, 2023 | 4.44M | +2.6% | +2.4% |
- Protagenic Therapeutics, Inc.new showed an increase of +63.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2024 period, Protagenic Therapeutics, Inc.new’s shares outstanding has declined by 98.2% (from 400.00 million shares to 7.24 million shares).
- The most recent figure is from Protagenic Therapeutics, Inc.new’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: